After a strong start to the day, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has given back its early gains and is down slightly to 5,711 points.
Four shares which have not let that hold them back are listed below. Here's why they have started the week with a bang:
The Bubs Australia Ltd (ASX: BUB) share price is up 24% to 14.5 cents. Today's gain means that the infant formula and baby food company's shares are up a remarkable 70% since this time last week. The catalyst for this gain was an agreement signed with China-based Kaola.com. As I said earlier, I think Bubs is certainly one to watch.
The Greencross Limited (ASX: GXL) share price is up 3% to $5.65 despite there being no news out of the integrated pet care company. But like my colleague wrote earlier today, I think Greencross looks like a bargain buy at the current share price. Because of this, I can't say I'm surprised to see its shares climbing higher.
The Metcash Limited (ASX: MTS) share price has climbed almost 6% to $2.31 after the release of its full-year results. On the top line Metcash delivered a 5.4% increase in revenue to $14.12 billion. On the bottom line, underlying profit after tax was up 9.3% to $194.8 million. Pleasingly, food earnings were in line with the previous year despite increased competition and difficult trading conditions.
The Wattle Health Australia Ltd (ASX: WHA) share price has jumped 8% to 48 cents. This morning the health and wellness food products company announced a supply agreement with Metcash. The agreement means that Wattle Health's GoldCare+ infant formula range will be made available to grocery retailers across Metcash's retail network.
